Tag Archives | biotechnology sector

FED No Change: Market Down 1% as Less Monetary Accommodation Likely in Future

Downside Risk to Economy Diminished So Less “Extreme Monetary Policy” In the Future? Market Stable with downward bias :S&P flat to down 18 pts-10 Year Bond Yield At 2.28% up 3.9% FED Is Optimistic  about the economy: housing, consumer sentiment, financial backdrop but with fiscal drag. Bond purchases are tied to the economy. The FED […]

Continue Reading 0

Gilead(GILD) and Abbott(ABT) Guidance Triggers Biotech Sell-Off

Healthcare Reform Impact on Gilead HIV Product Sales Surprises Analysts Gilead Sciences (GILD) lowered its 2010 sales forecast to a range of $7.4-$7.5B from $7.6-$7.8B citing recently enacted healthcare legislation. Net income for the quarter ended March 31 jumped from $854.9M or $0.92/sh. compared with $589.1M or $0.63/sh. in the Year ago period. Gilead’s first-quarter […]

Continue Reading 0